Trial intelligence / Profile preview

Topical tranexamic acid in endoscopic sinus surgery

IRCT20180730040640N1Phase 3Completed

Sponsor
Bushehr University of Medical Sciences
Start
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in chronic rhinosinusitis (CRS) comparing Tranexamic acid + phenylephrine with Phenylephrine control (2 arms). Primary endpoints: Bleeding during surgery and Quality of surgical field. Started Sep 2018; status: completed.

02

Drugs

tranexamic acidphenylephrine
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on IRCT20180730040640N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180730040640N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call